WHWK - Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc. Logo

WHWK - Whitehawk Therapeutics, Inc.

https://ir.whitehawktx.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. The company is headquartered in Morristown, New Jersey.

52W High
$3.81
52W Low
$1.39
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.59
Valuation
Attractive
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
12.33
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.62
EV/Revenue (<3 favorable)
3.48
P/S (TTM) (<3 favorable)
3.14
P/B (<3 favorable)
0.38
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
12.44%
Institutions (25–75% balanced)
67.64%
Shares Outstanding
47,109,300
Float
21,851,200
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
27,775,000
Gross Profit (TTM)
-21,582,000
EPS (TTM)
0.15
Profit Margin (>10% good)
0.99%
Operating Margin (TTM) (higher better)
-2.13%
ROE (TTM) (>15% strong)
0.18%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.34
Momentum
Bearish momentum
Value
0.0505
Previous
0.0358
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025